HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Virginia F Borges Selected Research
Virginia F Borges Research Topics
Disease
71
Breast Neoplasms (Breast Cancer)
01/2022 - 01/2003
49
Neoplasms (Cancer)
01/2022 - 11/2002
8
Neoplasm Metastasis (Metastasis)
11/2020 - 06/2009
6
Brain Neoplasms (Brain Tumor)
12/2021 - 07/2014
4
Triple Negative Breast Neoplasms
01/2021 - 01/2018
4
Melanoma (Melanoma, Malignant)
01/2019 - 03/2013
4
Disease Progression
10/2018 - 01/2009
2
Amenorrhea
07/2021 - 08/2014
2
Diarrhea
01/2018 - 07/2017
2
Lymphatic Metastasis
01/2016 - 08/2009
2
Noninfiltrating Intraductal Carcinoma (DCIS)
11/2015 - 08/2011
1
Vitamin D Deficiency
01/2021
1
Dyspareunia
12/2020
1
Musculoskeletal Pain
01/2019
1
Headache (Headaches)
01/2018
1
Nausea
01/2018
1
Fatigue
01/2018
1
Epistaxis (Nosebleed)
01/2018
1
Thrombocytopenia (Thrombopenia)
01/2018
Drug/Important Bio-Agent (IBA)
15
Hormones (Hormone)
IBA
01/2022 - 04/2005
12
Estrogen Receptors
IBA
01/2022 - 12/2008
7
Estrogens (Estrogen)
FDA Link
01/2018 - 12/2008
6
Phenobarbital (Luminal)
FDA Link
01/2022 - 07/2015
6
Biological Products
IBA
01/2022 - 10/2008
6
Biomarkers (Surrogate Marker)
IBA
01/2020 - 12/2008
5
tucatinib
IBA
01/2022 - 07/2017
5
Trastuzumab (Herceptin)
FDA Link
06/2021 - 01/2003
5
Tamoxifen
FDA Link
Generic
01/2013 - 04/2005
4
Collagen
IBA
01/2022 - 08/2011
4
Aromatase Inhibitors
IBA
04/2010 - 04/2005
3
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 07/2014
3
Fulvestrant (Faslodex)
FDA Link
01/2022 - 04/2005
3
pertuzumab
IBA
06/2021 - 01/2018
3
Proteins (Proteins, Gene)
FDA Link
11/2020 - 01/2009
3
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
01/2020 - 08/2011
3
Semaphorins (Semaphorin)
IBA
01/2020 - 11/2018
3
Cytokines
IBA
01/2019 - 04/2015
3
human ERBB2 protein
IBA
01/2018 - 01/2003
3
Ado-Trastuzumab Emtansine
IBA
01/2018 - 07/2014
3
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
09/2014 - 08/2011
3
4-azidobenzylcarazolol (pABC)
IBA
06/2013 - 06/2009
3
exemestane (Aromasin)
FDA Link
12/2008 - 04/2005
2
Pharmaceutical Preparations
IBA
01/2022 - 04/2010
2
Fibrillar Collagens
IBA
01/2022 - 08/2011
2
Immune Checkpoint Inhibitors
IBA
01/2021 - 10/2018
2
Phosphotransferases (Kinase)
IBA
09/2019 - 01/2018
2
Progesterone Receptors (Progesterone Receptor)
IBA
01/2019 - 12/2017
2
Estradiol (Delestrogen)
FDA Link
Generic
01/2019 - 01/2013
2
Progesterone
FDA Link
Generic
01/2018 - 06/2013
2
taxane
IBA
01/2018 - 01/2009
2
Antigens
IBA
01/2016 - 11/2002
2
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
09/2014 - 04/2014
2
Anthracyclines
IBA
01/2009 - 01/2003
2
Estrogen Receptor Modulators (Antiestrogen)
IBA
12/2008 - 04/2005
1
palbociclib
IBA
01/2022
1
Cyclin D1
IBA
01/2022
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
01/2022
1
neratinib
IBA
06/2021
1
atezolizumab
IBA
01/2021
1
pembrolizumab
IBA
01/2021
1
Opioid Analgesics (Opioids)
IBA
01/2021
1
Benzodiazepines
IBA
01/2021
1
Vitamin D
FDA Link
Generic
01/2021
1
Focal Adhesion Protein-Tyrosine Kinases
IBA
11/2020
1
Proteome
IBA
11/2020
1
Nucleic Acids
IBA
11/2020
1
Fibronectins (Fibronectin)
IBA
01/2020
1
p21-Activated Kinases
IBA
09/2019
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
09/2019
1
MLN 8237
IBA
09/2019
1
Aurora Kinase A
IBA
09/2019
1
Tryptophan (L-Tryptophan)
FDA Link
01/2019
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2019
1
tropomyosin kinase
IBA
01/2019
1
Kynurenine
IBA
01/2019
1
Interleukin-6 (Interleukin 6)
IBA
01/2019
1
Brain-Derived Neurotrophic Factor (BDNF)
IBA
01/2019
1
Enzymes
IBA
01/2019
1
Conditioned Culture Media
IBA
01/2019
1
Interleukin-8 (Interleukin 8)
IBA
01/2019
1
Ipilimumab
IBA
10/2018
1
Ibuprofen (Motrin)
FDA Link
Generic
10/2018
1
Tretinoin (Retinoic Acid)
FDA Link
Generic
10/2018
1
Lipids
IBA
10/2018
1
Prostaglandins
IBA
10/2018
1
ENMD 2076
IBA
01/2018
1
Drug Combinations
IBA
01/2018
Therapy/Procedure
27
Therapeutics
01/2022 - 01/2003
11
Drug Therapy (Chemotherapy)
07/2021 - 01/2003
5
Immunotherapy
01/2021 - 03/2013
3
Neoadjuvant Therapy
01/2022 - 01/2018
3
Segmental Mastectomy (Lumpectomy)
01/2022 - 08/2009
3
Radiotherapy
10/2021 - 07/2014
3
Mastectomy (Mammectomy)
10/2021 - 11/2015
3
Adjuvant Chemotherapy
02/2021 - 10/2016
3
Chemoprevention
12/2016 - 07/2013
2
Aftercare (After-Treatment)
11/2020 - 01/2018
1
Mammaplasty (Breast Reconstruction)
10/2021
1
Continuity of Patient Care
01/2021
1
Ovariectomy (Oophorectomy)
01/2019